Jo Wern Goh

INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES

Sonja Sorensen, Jo Wern Goh, Feng Pan et al. · International Journal of Technology Assessment in Health Care · 2012 · 74 citations

Medicine, Oncology, Pharmacoeconomics +17

Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States

Feng Pan, Jo Wern Goh, Gary Cutter et al. · Clinical Therapeutics · 2012 · 22 citations

Pharmacy, Neurology, Pharmacoeconomics +14

An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States

Sandra Milev, Marco DiBonaventura, Peter Quon et al. · Journal of Medical Economics · 2019 · 18 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK

Richard Lawson, James Ryan, F. King et al. · PharmacoEconomics · 2016 · 10 citations

Medicine, Pharmacoeconomics, Pharmacology +14